Total Payments
$27,494
2024 Payments
$1,091
Companies
47
Transactions
414
Medicare Patients
6,942
Medicare Billing
$737,642
Payment Breakdown by Category
Other$14,155 (51.5%)
Food & Beverage$10,533 (38.3%)
Travel$2,622 (9.5%)
Education$184.17 (0.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $14,155 | 6 | 51.5% |
| Food and Beverage | $10,533 | 391 | 38.3% |
| Travel and Lodging | $2,622 | 12 | 9.5% |
| Education | $184.17 | 5 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Sunovion Pharmaceuticals Inc. | $12,832 | 59 | $0 (2020) |
| Mylan Specialty L.P. | $4,618 | 22 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $2,406 | 73 | $0 (2024) |
| GlaxoSmithKline, LLC. | $997.24 | 74 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $812.59 | 29 | $0 (2023) |
| Veran Medical Technologies, Inc. | $742.23 | 1 | $0 (2017) |
| JAZZ PHARMACEUTICALS INC. | $704.70 | 18 | $0 (2024) |
| Actelion Pharmaceuticals US, Inc. | $619.34 | 17 | $0 (2024) |
| GENZYME CORPORATION | $595.44 | 17 | $0 (2024) |
| Amgen Inc. | $337.94 | 10 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,091 | 47 | Actelion Pharmaceuticals US, Inc. ($305.59) |
| 2023 | $495.08 | 29 | AstraZeneca Pharmaceuticals LP ($124.52) |
| 2022 | $1,354 | 44 | AstraZeneca Pharmaceuticals LP ($480.56) |
| 2021 | $1,798 | 47 | AstraZeneca Pharmaceuticals LP ($759.85) |
| 2020 | $754.08 | 36 | AstraZeneca Pharmaceuticals LP ($195.22) |
| 2019 | $8,051 | 81 | Mylan Specialty L.P. ($4,496) |
| 2018 | $5,971 | 50 | Sunovion Pharmaceuticals Inc. ($4,798) |
| 2017 | $7,979 | 80 | Sunovion Pharmaceuticals Inc. ($6,058) |
All Payment Transactions
414 individual payment records from CMS Open Payments — Page 1 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $14.98 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 12/17/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $20.50 | General |
| Category: Immunology | ||||||
| 12/17/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $20.43 | General |
| Category: Respiratory | ||||||
| 12/09/2024 | Avadel CNS Pharmaceuticals, LLC | LUMRYZ (Drug) | Food and Beverage | In-kind items and services | $16.96 | General |
| Category: CENTRAL NERVOUS SYSTEM CNS NEUROLOGY | ||||||
| 12/03/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $18.53 | General |
| Category: IMMUNOLOGY | ||||||
| 11/25/2024 | Amgen Inc. | — | Food and Beverage | In-kind items and services | $19.45 | General |
| 11/20/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $143.66 | General |
| Category: Cardiology | ||||||
| 11/14/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $23.96 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/06/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $121.83 | General |
| Category: Cardiology | ||||||
| 10/30/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.45 | General |
| Category: Immunology | ||||||
| 10/29/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.76 | General |
| Category: RESPIRATORY | ||||||
| 10/22/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: RESPIRATORY | ||||||
| 10/17/2024 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $12.79 | General |
| Category: HFCWO | ||||||
| 10/14/2024 | Avadel CNS Pharmaceuticals, LLC | LUMRYZ (Drug) | Food and Beverage | In-kind items and services | $22.50 | General |
| Category: CENTRAL NERVOUS SYSTEM CNS NEUROLOGY | ||||||
| 10/10/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $1.72 | General |
| Category: IMMUNOLOGY | ||||||
| 10/09/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $11.45 | General |
| Category: Inflammation | ||||||
| 10/03/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $16.49 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 09/30/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $17.51 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 09/25/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $21.78 | General |
| Category: Immunology | ||||||
| 09/17/2024 | Axsome Therapeutics, Inc. | Sunosi (Drug) | Food and Beverage | In-kind items and services | $24.05 | General |
| Category: Neurology | ||||||
| 09/17/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $17.85 | General |
| Category: Immunology | ||||||
| 09/09/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $21.37 | General |
| Category: NEUROLOGY | ||||||
| 09/04/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $5.86 | General |
| Category: RESPIRATORY | ||||||
| 08/26/2024 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $30.23 | General |
| Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease | ||||||
| 08/19/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $20.09 | General |
| Category: Cardiology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 1,475 | 2,717 | $309,045 | $153,478 |
| 2022 | 21 | 1,555 | 2,927 | $332,840 | $164,729 |
| 2021 | 22 | 1,885 | 3,468 | $376,630 | $206,799 |
| 2020 | 22 | 2,027 | 3,867 | $403,405 | $212,636 |
Total Patients
6,942
Total Services
12,979
Medicare Billing
$737,642
Procedure Codes
95
All Medicare Procedures & Services
95 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 376 | 876 | $105,120 | $52,921 | 50.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 130 | 666 | $60,100 | $40,559 | 67.5% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 102 | 131 | $23,580 | $13,131 | 55.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 90 | 122 | $18,540 | $10,701 | 57.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 90 | 90 | $20,700 | $9,059 | 43.8% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 13 | 85 | $11,900 | $7,788 | 65.4% |
| 95800 | Sleep study including heart rate, breathing, and sleep time | Office | 2023 | 37 | 38 | $11,250 | $3,894 | 34.6% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 84 | 85 | $8,460 | $2,219 | 26.2% |
| 95810 | Sleep study in sleep lab (6 years or older) | Office | 2023 | 18 | 18 | $8,640 | $1,626 | 18.8% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 39 | 39 | $4,290 | $1,447 | 33.7% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Office | 2023 | 15 | 16 | $8,640 | $1,406 | 16.3% |
| 94660 | Therapy procedure using a positive pressure ventilator | Office | 2023 | 29 | 29 | $2,900 | $1,380 | 47.6% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Office | 2023 | 47 | 47 | $5,640 | $1,362 | 24.1% |
| 99406 | Smoking and tobacco use intensive counseling, 4-10 minutes | Office | 2023 | 45 | 90 | $1,800 | $1,227 | 68.1% |
| G0296 | Counseling visit to discuss need for lung cancer screening using low dose ct scan (ldct) (service is for eligibility determination and shared decision making) | Office | 2023 | 34 | 35 | $1,400 | $923.78 | 66.0% |
| 94200 | Test to measure largest amount of air breathed in an out | Office | 2023 | 78 | 79 | $3,950 | $822.82 | 20.8% |
| 94640 | Inhalation treatment for airway obstruction or sputum production | Office | 2023 | 84 | 105 | $3,150 | $662.49 | 21.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 19 | 19 | $570.00 | $557.84 | 97.9% |
| 95806 | Sleep study including heart rate, breathing, airflow, and effort | Office | 2023 | 16 | 16 | $3,200 | $503.85 | 15.7% |
| 94664 | Evaluation of use of breathing device | Office | 2023 | 29 | 31 | $775.00 | $359.60 | 46.4% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Facility | 2023 | 30 | 30 | $1,350 | $264.48 | 19.6% |
| Q2035 | Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (afluria) | Office | 2023 | 12 | 12 | $360.00 | $256.65 | 71.3% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2023 | 28 | 28 | $1,680 | $211.14 | 12.6% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2023 | 30 | 30 | $1,050 | $196.62 | 18.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 407 | 909 | $109,080 | $56,121 | 51.4% |
About Dr. Moin Ranginwala, MD
Dr. Moin Ranginwala, MD is a Critical Care Medicine healthcare provider based in Springfield, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/31/2006. The National Provider Identifier (NPI) number assigned to this provider is 1134166317.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Moin Ranginwala, MD has received a total of $27,494 in payments from pharmaceutical and medical device companies, with $1,091 received in 2024. These payments were reported across 414 transactions from 47 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($14,155).
As a Medicare-enrolled provider, Ranginwala has provided services to 6,942 Medicare beneficiaries, totaling 12,979 services with total Medicare billing of $737,642. Data is available for 4 years (2020–2023), covering 95 distinct procedure/service records.
Ad
Practice Information
- Specialty Critical Care Medicine
- Other Specialties Pulmonary Disease
- Location Springfield, OH
- Active Since 05/31/2006
- Last Updated 06/17/2011
- Taxonomy Code 207RC0200X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1134166317
Products in Payments
- UTIBRON (Drug) $7,900
- LONHALA MAGNAIR (Drug) $4,900
- Yupelri (Drug) $4,546
- Spin (Device) $742.23
- DUPIXENT (Biological) $598.63
- BREZTRI (Drug) $578.63
- FASENRA (Biological) $540.81
- BEVESPI AEROSPHERE (Drug) $397.62
- SUNOSI (Drug) $396.28
- FASENRA (Drug) $381.37
- TRELEGY ELLIPTA (Drug) $358.67
- TEZSPIRE (Biological) $357.81
- OFEV (Drug) $352.14
- OPSUMIT (Drug) $336.91
- NUCALA (Biological) $294.36
- UPTRAVI (Drug) $282.43
- ZERBAXA (Drug) $171.48
- Prolastin-C Liquid (Biological) $157.14
- DUPIXENT (Drug) $155.15
- (8874) inCourage (Device) $148.68
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Critical Care Medicine Doctors in Springfield
William Mcgee, Md, MD
Critical Care Medicine — Payments: $65,613
Critical Care Medicine $65,613
Dr. Nakul Ravikumar, Md, MD
Critical Care Medicine — Payments: $33,243
Critical Care Medicine $33,243
Victor Pinto-Plata, M.d, M.D
Critical Care Medicine — Payments: $17,786
Critical Care Medicine $17,786
Chih Chen, M.d, M.D
Critical Care Medicine — Payments: $6,423
Critical Care Medicine $6,423
Silvia Alvarez De Leon, M.d, M.D
Critical Care Medicine — Payments: $5,100
Critical Care Medicine $5,100
Dr. Pradeep Kulkarni, M.d, M.D
Critical Care Medicine — Payments: $4,363
Critical Care Medicine $4,363